Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort Study.

Clinical drug investigation·2026
Same author

SARS-CoV-2 vaccination and attenuation of breakthrough infection severity: A systematic global review and meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines.

Journal of virology·2026
Same author

Seroprevalence of COVID-19 among healthcare workers in Hong Kong during the first 2 years of the COVID-19 pandemic (2020-2021): a longitudinal cohort study.

BMJ open·2026
Same author

Epidemiological Trends of COVID-19 Infection and Symptom Incidence in China Following the Adjustment of Zero-COVID Policy: A Prospective, Community-Based Cohort Study.

Transboundary and emerging diseases·2026
Same author

Birth imprinting effects on the antibody responses of H7N9 patients from 2013-2018 in China.

Communications medicine·2026
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026
Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026
Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026
Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026
查看所有相关文章

相关实验视频

Updated: Jun 10, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K

疫苗有效性研究的改进方法

George N Okoli1, Benjamin J Cowling1,2

  • 1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China.

The Journal of infectious diseases
|October 15, 2024
PubMed
概括
此摘要是机器生成的。

评估疫苗有效性 (VE) 对公共卫生至关重要. 最近的发现强调应对相关的疫苗接种行为,使用负对照,并考虑先前的感染,以提高VE研究的准确性和可靠性.

关键词:
疫苗的有效性 疫苗的有效性评价 评价 评价 评价方法 方法 方法 方法.测试负面的设计.

更多相关视频

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

相关实验视频

Last Updated: Jun 10, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

科学领域:

  • 流行病学 流行病学
  • 公共卫生 公共卫生
  • 生物统计学 生物统计学

背景情况:

  • 评估公共卫生对疫苗接种计划的投资对于效率和有效性至关重要.
  • 疫苗有效性 (VE) 研究,特别是测试负面设计 (TND),对于确认疫苗影响和指导改进至关重要.
  • TND提供了简单性和成本效益,但由于不一致的症状定义和回顾性数据可能会受到损害.

研究的目的:

  • 总结最近的发现,以改进 VE 估计方法.
  • 突出解决 VE 研究中的特定偏见的重要性.
  • 提高疫苗有效性数据的准确性和可靠性.

主要方法:

  • 总结最近关于 VE 估计的研究结果.
  • 确定影响 VE 研究有效性的关键因素.
  • 建议对流行病学研究进行方法调整.

主要成果:

  • 在估计VE时,需要考虑相关的疫苗接种行为.
  • 负控制变量可以有效地减少VE研究中的混.
  • 建议考虑以前的感染史,以提高VE研究的准确性.

结论:

  • 精细的 VE 估计方法对于准确的公共卫生评估至关重要.
  • 解决 VE 研究中的方法限制,确保了政策决策的可靠数据.
  • 改进VE研究设计有助于更有效的疫苗接种计划策略.